Litholink, a LabCorp subsidiary, has developed a programmatic approach to comprehensively treat kidney stone disease. Using this approach, we are able to reduce the rate of kidney stone recurrence up to 80%.
Our Kidney Stone Patient Results Report
Litholink’s report provides time sequential data and analysis of stone risk factors with therapeutic suggestions.
Click below to sign up for the Litholink Kidney Stone Prevention program!
Our Kidney Stone Prevention Program
Dr. Fredric Coe, a leading expert in kidney stone disease, founded Litholink to bring state-of-the-art kidney stone treatment techniques to physicians nationwide.